Establishing consensus on the implementation of Anticoagulation Stewardship Program with cardiologists in Pakistan: A Delphi study. [PDF]
Razzaq W, Atif M, Arshad K, Masood I.
europepmc +1 more source
Erratum to “Non-vitamin K antagonist oral anticoagulant reversal: hope is on the horizon” [The American Journal of Surgery 212 (1) 160-164] [PDF]
Brian K. Yorkgitis
openalex +1 more source
MANAGEMENT OF TOOTH EXTRACTIONS IN PATIENTS RECEIVING THE NEW ORAL ANTICOAGULANTS
Lyudmila Vladimirova‐Kitova +3 more
openalex +1 more source
Clopidogrel, an antiplatelet agent, is currently licensed in the United Kingdom for the prevention and treatment of atherothrombotic events in cerebrovascular disease, coronary artery disease and peripheral arterial disease. Clopidogrel requires metabolic activation by the cytochrome P450 enzyme CYP2C19 to be effective.
Cinzia Dello Russo +22 more
wiley +1 more source
Anticoagulation therapy for intra-abdominal hypertension in patients with acute pancreatitis. [PDF]
Ge Y +9 more
europepmc +1 more source
115Anticoagulation in atrial fibrillation – a single-centre audit on patient education, stroke and bleeding risk assessments and use of direct oral anticoagulants (DOACs) [PDF]
SM Ng, Belén San José, Abhishek Sethi
openalex +1 more source
Aim Our international cohort study assessed the comparative effectiveness and safety of direct oral anticoagulants (DOACs) and vitamin K antagonists (VKAs) among patients with non‐valvular atrial fibrillation (NVAF) using antiarrhythmic drugs. Methods Using the United Kingdom's (UK's) Clinical Practice Research Datalink Aurum and Québec claims data, we
Fabian Maximilian Meinert +5 more
wiley +1 more source
Editorial: Venous thromboembolism and pregnancy
Bernard Tardy, Laurent Bertoletti
doaj +1 more source
The association of anticoagulant use and hospitalization for hemorrhagic stroke among older adults aged 75 or older: A propensity score-matched study. [PDF]
Mitsutake S +3 more
europepmc +1 more source

